- Home
- NEA vs XENE Comparison
NEA vs XENE Comparison
Compare NEA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEA
- XENE
- Stock Information
- Founded
- NEA 2002
- XENE 1996
- Country
- NEA United States
- XENE Canada
- Employees
- NEA N/A
- XENE N/A
- Industry
- NEA Finance/Investors Services
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NEA Finance
- XENE Health Care
- Exchange
- NEA Nasdaq
- XENE Nasdaq
- Market Cap
- NEA 3.4B
- XENE 2.9B
- IPO Year
- NEA N/A
- XENE 2014
- Fundamental
- Price
- NEA $11.35
- XENE $41.69
- Analyst Decision
- NEA
- XENE Strong Buy
- Analyst Count
- NEA 0
- XENE 11
- Target Price
- NEA N/A
- XENE $52.73
- AVG Volume (30 Days)
- NEA 803.4K
- XENE 788.6K
- Earning Date
- NEA 01-01-0001
- XENE 11-11-2025
- Dividend Yield
- NEA 4.23%
- XENE N/A
- EPS Growth
- NEA N/A
- XENE N/A
- EPS
- NEA N/A
- XENE N/A
- Revenue
- NEA N/A
- XENE $7,500,000.00
- Revenue This Year
- NEA N/A
- XENE N/A
- Revenue Next Year
- NEA N/A
- XENE $207.88
- P/E Ratio
- NEA N/A
- XENE N/A
- Revenue Growth
- NEA N/A
- XENE N/A
- 52 Week Low
- NEA $9.20
- XENE $26.74
- 52 Week High
- NEA $11.37
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- NEA 53.91
- XENE 64.43
- Support Level
- NEA $11.38
- XENE $39.35
- Resistance Level
- NEA $11.47
- XENE $41.66
- Average True Range (ATR)
- NEA 0.09
- XENE 1.49
- MACD
- NEA -0.01
- XENE 0.20
- Stochastic Oscillator
- NEA 46.55
- XENE 74.79
About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.